Transcriptome data from clinical samples revealed that expression of both MAZ and RACGAP1 was increased in BRCA tumor tissue than that in normal tissue, and there was significant positive correlation between MAZ and RACGAP1 (Fig. S6). This evidence concerns the gene MAZ and invasive breast carcinoma.